Experimental Weight Loss Injection Reta Causes Stir Amidst Black Market Sales
Translated & summarized from Mako by baba
An experimental weight loss injection called Retatrutide (Reta) is gaining popularity online despite not being approved for use. Users are purchasing it through black market channels like TikTok and Telegram, reporting significant weight loss. Doctors and health authorities warn of the dangers of unsupervised use and the potential for counterfeit or mislabeled products, citing a case of severe injury in Australia. While Reta shows promise in clinical trials, its use is currently restricted to approved research settings.
The story in 6 lines · by baba
- An experimental weight loss drug, Retatrutide (Reta), is being sold illegally online despite lacking regulatory approval.
- Users report significant weight loss and appetite control, with some claiming fewer side effects than approved medications.
- Doctors and health authorities warn of serious risks, including the possibility of counterfeit or dangerously mislabeled substances.
- A case in Australia involved a patient hospitalized after using a black market product that contained the wrong active ingredient.
- Retatrutide is still in clinical trials, with potential approval anticipated around 2027, and should only be used under medical supervision.
- The unregulated market poses significant dangers due to unknown contents, concentrations, and production conditions.
A new experimental weight loss injection, Retatrutide, or Reta, is generating significant buzz, despite not yet being approved for public use. While still in clinical trials, social media platforms are flooded with reports of drastic weight loss, recommendations, and black market deals for the drug. Doctors are warning of the dangers of unsupervised use, but this has not deterred individuals seeking rapid weight loss.
Reta works by targeting three hormone receptors (GLP-1, GIP, and glucagon), unlike previous drugs that targeted one or two. This mechanism has shown impressive weight loss of up to 30% in studies, though direct comparisons and long-term safety data are still pending. Nevertheless, online platforms are rife with testimonials of significant weight reduction and discussions about dosages and suppliers.
Despite the lack of regulatory approval, many Israelis are acquiring Reta through unofficial channels like Telegram and TikTok. One user, a 35-year-old man from southern Israel, reported losing 35 kilograms in six months, attributing his success to Reta after trying numerous other diets. He noted that Reta helped control his appetite, which other approved medications did not, and claimed to experience fewer side effects than with other drugs.
However, medical professionals caution that individual experiences do not negate the drug's potential risks. The Australian Therapeutic Goods Administration (TGA) issued a warning after a case where a patient required hospitalization due to severe vomiting and esophageal tearing from a product sold as Reta, which was found to contain a dangerous concentration of semaglutide instead of Retatrutide.
Dr. Raz Hagouel, Director of the Obesity Center in Tel Aviv, stated that Reta is still considered an unapproved drug globally and is not cleared for routine use in Israel or elsewhere. While positive results from Phase III trials have been published, with potential approval anticipated around 2027, he stressed that its use should strictly be within approved clinical trials and under medical supervision until then. He also highlighted the risks associated with the unregulated market, where the contents and production conditions of the drug are often unknown, emphasizing that even if the drug is eventually proven safe, the black market versions may not be.